KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Gsk (GSK) Times Interest Earned (2016 - 2026)

Gsk has reported Times Interest Earned over the past 18 years, most recently at -$13.73 for Q1 2026.

  • For Q1 2026, Times Interest Earned changed 0.38% year-over-year to -$13.73; the TTM value through Mar 2026 reached -$6.6, down 7.29%, while the annual FY2025 figure was $11.32, 88.26% up from the prior year.
  • Times Interest Earned for Q1 2026 was -$13.73 at Gsk, down from -$1.57 in the prior quarter.
  • Over five years, Times Interest Earned peaked at -$1.21 in Q3 2024 and troughed at -$15.53 in Q3 2025.
  • A 5-year average of -$8.47 and a median of -$9.46 in 2024 define the central range for Times Interest Earned.
  • Biggest five-year swings in Times Interest Earned: surged 88.69% in 2024 and later crashed 1181.59% in 2025.
  • Year by year, Times Interest Earned stood at -$3.84 in 2022, then plummeted by 38.91% to -$5.33 in 2023, then increased by 12.09% to -$4.69 in 2024, then surged by 66.52% to -$1.57 in 2025, then tumbled by 775.01% to -$13.73 in 2026.
  • Business Quant data shows Times Interest Earned for GSK at -$13.73 in Q1 2026, -$1.57 in Q4 2025, and -$15.53 in Q3 2025.